Root Financial Partners
PRAX icon

Root Financial Partners’s Praxis Precision Medicines PRAX Stock Holding History

Root Financial Partners’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.33K Buy
+8
New +$2.65K ﹤0.01% 2577
2026
Q2 		– Sell
-7
Closed -$2.26K – 2454
2026
Q1 		$2.26K Buy
+7
New +$2.16K ﹤0.01% 2269

Other funds holding PRAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $109B AUM 51.53% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Emerald Mutual Fund Advisers Trust
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return

Root Financial Partners's PRAX Position: Q3 2026 in Review

Root Financial Partners opened a new position in Praxis Precision Medicines (PRAX) in Q3 2026: 8 shares worth $2.33K. The stake represents ﹤0.01% of the portfolio and ranks #2577 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in PRAX as recently as Q1 2026.

Root Financial Partners first reported a position in PRAX in Q1 2026 and has held it in 2 quarters since. 153 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

  • Root Financial Partners held 8 shares of Praxis Precision Medicines worth $2.33K as of Q3 2026.
  • Praxis Precision Medicines was a new Root Financial Partners position in Q3 2026.
  • Praxis Precision Medicines made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #2577 holding.
  • Root Financial Partners first reported a position in Praxis Precision Medicines in Q1 2026 and has held it in 2 quarters since.
  • 153 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.